Milan, Italy

Giovanni Macchia

This inventor holds 1 USPTO granted patent. Top assignee: Dompe S.p.a.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giovanni Macchia. Retrieved from https://idiyas.com/inventor/giovanni-macchia-xi3exgem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giovanni Macchia: Innovator in IL-1 Receptor Antagonists

Introduction

Giovanni Macchia is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of IL-1 receptor antagonists. His work focuses on enhancing the inhibitory activity of these compounds, which are crucial in treating various inflammatory conditions.

Latest Patents

Giovanni holds a patent for "IL-1 receptor antagonists with enhanced inhibitory activity." This innovation represents a step forward in therapeutic options for patients suffering from diseases linked to inflammation.

Career Highlights

Giovanni Macchia is currently employed at Dompe S.p.a., a prominent pharmaceutical company known for its commitment to research and development. His role at the company allows him to work on cutting-edge projects that aim to improve patient outcomes through innovative treatments.

Collaborations

Throughout his career, Giovanni has collaborated with esteemed colleagues, including Diana Boraschi and Paola Bossu. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Giovanni Macchia's contributions to the field of pharmaceuticals, particularly through his patent on IL-1 receptor antagonists, highlight his role as an innovator. His work continues to impact the medical community positively, paving the way for advancements in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…